VICR Price Prediction Next Week
VICR Stock Price Prediction and Recommendation
News Analysis:
- Analyst Rating: Quinn Bolton from Needham has maintained a Hold rating on Vicor (VICR), with the overall analyst consensus suggesting a Moderate Buy. However, insider activity indicates negative sentiment, with increased selling by corporate insiders, including a notable sale by Director Estia Eichten.
- Recent Performance: VICR stock surged 27.80% after reporting better-than-expected Q4 financial results, but it is currently considered overvalued by 30%, trading at $52.79 compared to an intrinsic value of $40.48.
Technical Analysis:
- Price Action: VICR closed at $55.37 on 2025-03-24, with a pre-market percentage change of +2.50% and a regular market change of +3.23%.
- RSI: The RSI_6 is 47.24, indicating the stock is not in overbought territory but is approaching a neutral zone.
- MACD: The MACD_12_26_9 is slightly negative (-0.32), suggesting a bearish trend.
- Fibonacci Levels: The Fibonacci pivot point is at $52.25, with resistance levels at $56.21 and $58.65, and support levels at $48.29 and $45.85.
Price Prediction:
Based on the technical indicators and news sentiment, VICR is expected to face resistance at $56.21 and may decline towards the support level of $48.29. The stock is likely to trade in a range between $48.29 and $56.21 in the next trading week.
Recommendation:
Given the current overvaluation and insider selling activity, it is recommended to sell VICR at the current price of $55.37, targeting a price of $52.40 in the next trading week.
VICR Similar Chart Price Prediction
The price of VICR is predicted to go up 1.61%, based on the high correlation periods with BIO. The similarity of these two price pattern on the periods is 93.35%.
VICR
BIO
Up: 1.61%Similarity: 93.35%
VICR Revenue Forecast
VICR EPS Forecast
VICR FAQs
What is VICR revenue forecast for next quarter？
VICR Analyst's Forecast
Richard Shannon
Craig-Hallum
Hold
2024-10-23
Price Target
$35 → $43
Downside
-12.94%
Craig-Hallum analyst Richard Shannon raised the firm's price target on Vicor to $43 from $35 and keeps a Hold rating on the shares. The firm notes Vicor's Q3 results that drove the stock up 15% in the aftermarket on Tuesday do not seem supportable in the near term, as it finds them to be somewhat lower quality than the headline appears. As such, Craig-Hallum sees the stock fading in the near term and would not be a buyer on this reaction.
